Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Case-Based Roundtable

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Polls

Editorial Advisory Board

Partners

Subscribe

 and joined the MJH Life Sciences team in June 2022. She attended Otterbein University in Westerville, Ohio, and earned a Bachelor of Arts degree in literary studies with minors in creative writing and film studies. Prior to health care news, Kaitlyn worked in industrial marketing. She enjoys cooking, reading, and tending to her house plants. 

Articles

Learn more about the in-depth topics covered in the June 2024 print issue of Dermatology Times.

Discovering Dermatology Times: June 2024 Print

Peter Prieto, MD, MPH, shares details of the IOV-COM-202 trial.  

Evaluating Lifileucel and Pembrolizumab in Advanced Melanoma 

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Researchers found the assessment accounted for those with moderate impact, allowing clinicians to create improved treatment plans for patients.

Validation of Improved QoL Assessment for Moderate Psoriasis

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Dermatology Times is recapping our top expert interviews from the month of June.

Interview Intersection: Expert Interviews From June 2024

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Twitter

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

Strategic Alliance Partnership

1rem

Strategic Alliance Partners

 Pediatric Dermatology Research Alliance

Acne and Rosacea Meeting

Biologics Coordinators of Dermatology

Cosmetic Bootcamp

Dermatology Research and Education Foundation

Elevate Derm: PA & NP Conference

HS Foundation

International HyperHidrosis Society (IHhS)

Masterclasses in Dermatology

Music City SCALE: Symposium for Cosmetic Advances & Laser Education

National Eczema Association (NEA)

National Infusion Center Association (NICA)

New Frontiers in Cosmetic Medicine & Medical Dermatology

Revolutionizing Atopic Dermatitis

SDNP

SDPA

Science of Skin Care Summit

Skin Cancer Foundation

Society for Pediatric Dermatology

Spherix

Yale - Dept of Dermatology